MS4A1 and neoplasm: In addition, Schuster et al. performed IHC, RNA sequencing, and Whole-Exome Sequencing (WES) on tumor samples from patients with r/r B-NHL treated with Mosunetuzumab monotherapy to evaluate CD20 expression [99].